PHIBRO ANIMAL HEALTH CORP
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
PAHC$34.64+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | | | | | | | | | | | |
| · · · · · · · · · · · · · · · · Accumulated · · · | ||||||||||||||||||||
| · · Shares of · · · · · · · · · · · · · · Other · · · | ||||||||||||||||||||
| · · Common · · Common · · Preferred · · Paid-in · · Retained · · Comprehensive · · · | ||||||||||||||||||||
| · · Stock · · Stock · · Stock · · Capital · · Earnings · · Loss · · Total | ||||||||||||||||||||
| · · (unaudited) | ||||||||||||||||||||
| · · (in thousands, except share and per share amounts) | ||||||||||||||||||||
| As of June 30, 2026 | | 40,564,716 | | $4 | | $— | | $138,592 | | $352,958 | | $(106,077) | | $385,477 | ||||||
| Comprehensive income | | — | | | — | | | — | | | — | | | 29,520 | | | 6,739 | | | 36,259 |
| Shares issued pursuant to stock incentive plan | | 36,887 | | | — | | | — | | | — | | | — | | | — | | | — |
| Dividends declared ($0.12 per share) | | — | | | — | | | — | | | — | | | (4,872) | | | — | | | (4,872) |
| Stock-based compensation expense | — | | — | | — | | 804 | | — | | — | | 804 | |||||||
| As of September 30, 2026 | | 40,601,603 | | $4 | | $— | | $139,396 | | $377,606 | | $(99,338) | | $417,668 | ||||||
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · · · · · · · | ||||||||||||||||||||
| · · · · · · · · · · · · · · · · Accumulated · · · | ||||||||||||||||||||
| · · Shares of · · · · · · · · · · · · · · Other · · · | ||||||||||||||||||||
| · · Common · · Common · · Preferred · · Paid-in · · Retained · · Comprehensive · · · | ||||||||||||||||||||
| · · Stock · · Stock · · Stock · · Capital · · Earnings · · Loss · · Total | ||||||||||||||||||||
| · · (unaudited) | ||||||||||||||||||||
| · · (in thousands, except share and per share amounts) | ||||||||||||||||||||
| As of June 30, 2025 | | 40,533,608 | | $4 | | $— | | $136,995 | | $272,701 | | $(124,018) | | $285,682 | ||||||
| Comprehensive income | — | | | — | | | — | | | — | | | 26,527 | | | 3,997 | | 30,524 | ||
| Dividends declared ($0.12 per share) | | — | | | — | | | — | | | — | | | (4,864) | | | — | | | (4,864) |
| Stock-based compensation expense | — | | — | | — | | 339 | | — | | — | | 339 | |||||||
| As of September 30, 2025 | | 40,533,608 | | $4 | | $— | | $137,334 | | $294,364 | | $(120,021) | | $311,681 | ||||||
The accompanying notes are an integral part of these consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.